Zyclara

Zyclara (Imiquimod) is a topical cream used for skin conditions like actinic keratosis and superficial basal cell carcinoma. It works by stimulating the immune system to treat abnormal skin growths. This product is for external use only.

Zyclara is commonly used to treat actinic keratosis, a precancerous skin condition caused by sun exposure. It is also prescribed for superficial basal cell carcinoma, a type of skin cancer. The cream helps reduce abnormal skin cells by activating the body’s natural immune response. It may also be used for external genital warts in adults.

Zyclara works by boosting the immune system to target and eliminate abnormal skin cells. Users may notice redness, swelling, or itching at the application site as the treatment takes effect. These effects are part of the body’s response to the active ingredient. Results vary depending on the condition being treated.

Zyclara is for external use only and should not be applied to open wounds or broken skin. Avoid contact with eyes, lips, and nostrils. Wash hands thoroughly after application. If severe skin reactions occur, discontinue use and consult a healthcare provider. Keep out of reach of children.

Zyclara has minimal systemic absorption, reducing the risk of drug interactions. However, concurrent use of other topical medications on the same area may affect efficacy. Avoid using other immune-modulating treatments without medical advice. Alcohol and certain medications may increase skin sensitivity.